Stocks
GDR MD Medical Group Inv. PLC Financial Statements (MDMG) |
||||||||||
| Мать и Дитя (MD)smart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 23.03.2020 | 22.03.2021 | 28.03.2022 | 04.04.2023 | 01.04.2024 | 29.08.2024 | ||||
| Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
| Financial report URL | ||||||||||
| Annual report URL | ||||||||||
| Presentation URL | ||||||||||
| Revenue, bln rub | ? | 16.2 | 19.1 | 25.2 | 25.2 | 27.6 | 30.5 | |||
| Operating Income, bln rub | 3.13 | 4.50 | 6.62 | 4.97 | 7.51 | 8.34 | ||||
| EBITDA, bln rub | ? | 4.64 | 6.00 | 8.28 | 7.92 | 9.22 | 5.12 | |||
| Net profit, bln rub | ? | 2.64 | 4.20 | 6.10 | 6.01 | 7.82 | 9.34 | |||
| Net profit not adj., bln rub | ? | 6.14 | 4.72 | |||||||
| OCF, bln rub | ? | 4.96 | 6.52 | 8.50 | 7.73 | 9.38 | 10.2 | |||
| CAPEX, bln rub | ? | 3.96 | 3.90 | 3.79 | 1.11 | 3.58 | 3.09 | |||
| FCF, bln rub | ? | 0.110 | 2.19 | 4.29 | 6.47 | 6.00 | 8.69 | |||
| Dividend payout, bln rub | 1.39 | 2.16 | 1.35 | 0.640 | 13.8 | |||||
| Dividend, rub/share | ? | 18.5 | 28.8 | 18 | 8.55 | 183 | ||||
| Ordinary share dividend yield, % | 6.0% | 6.3% | 2.3% | 2.0% | 0.0% | 21.1% | ||||
| Dividend payout ratio, % | 53% | 52% | 22% | 11% | 0% | 148% | ||||
| OPEX, bln rub | 2.65 | 2.62 | 3.37 | 4.82 | 3.77 | 4.26 | ||||
| Cost of production, bln rub | 10.4 | 12.0 | 15.2 | 15.4 | 16.3 | 17.9 | ||||
| Amortization, bln rub | 1.7 | 1.7 | ||||||||
| Employment expenses, bln rub | 7.13 | 7.67 | 9.54 | 10.1 | 11.1 | |||||
| Interest expenses, bln rub | 0.405 | 0.380 | 0.363 | 0.262 | ||||||
| Assets, bln rub | 28.7 | 32.0 | 34.3 | 33.2 | 41.3 | 46.4 | ||||
| Net Assets, bln rub | ? | 17.5 | 19.6 | 22.8 | 26.8 | 34.6 | 28.6 | |||
| Debt, bln rub | 7.10 | 6.80 | 5.51 | 0.600 | 0.876 | 1.28 | ||||
| Cash, bln rub | 3.06 | 3.90 | 3.59 | 4.46 | 9.89 | 14.6 | ||||
| Net debt, bln rub | 4.04 | 2.90 | 1.92 | -3.86 | -9.02 | -13.3 | ||||
| Ordinary share price, rub | 308.0 | 457.4 | 798.9 | 419.7 | 775.3 | 866.8 | ||||
| Number of ordinary shares, mln | 75.1 | 75.1 | 75.1 | 75.1 | 75.1 | 75.1 | ||||
| Free Float, % | 22.3% | 22.3% | 32.1% | |||||||
| Insider ownership, % | 67.9% | 67.9% | ||||||||
| Market cap, bln rub | 23.1 | 34.4 | 60.0 | 31.5 | 58.2 | 65.1 | ||||
| EV, bln rub | ? | 27.2 | 37.3 | 61.9 | 27.7 | 49.2 | 51.8 | |||
| Book value, bln rub | 15.3 | 17.4 | 20.7 | 24.8 | 32.4 | 26.4 | ||||
| EPS, rub | ? | 35.1 | 55.9 | 81.2 | 79.9 | 104.1 | 124.4 | |||
| FCF/share, rub | 1.46 | 29.1 | 57.1 | 86.1 | 79.9 | 115.7 | ||||
| BV/share, rub | 204.3 | 231.5 | 275.4 | 330.0 | 430.9 | 351.3 | ||||
| EBITDA margin, % | ? | 28.7% | 31.4% | 32.8% | 31.4% | 33.4% | 16.8% | |||
| Net margin, % | ? | 16.3% | 22.0% | 24.2% | 23.8% | 28.3% | 30.6% | |||
| FCF yield, % | ? | 0.5% | 6.4% | 7.1% | 20.5% | 10.3% | 13.3% | |||
| ROE, % | ? | 15.0% | 21.4% | 26.7% | 22.4% | 22.6% | 32.7% | |||
| ROA, % | ? | 9.2% | 13.1% | 17.8% | 18.1% | 18.9% | 20.1% | |||
| P/E | ? | 8.77 | 8.18 | 9.84 | 5.25 | 7.45 | 6.97 | |||
| P/FCF | 210.4 | 15.7 | 14.0 | 4.87 | 9.71 | 7.49 | ||||
| P/S | ? | 1.43 | 1.80 | 2.38 | 1.25 | 2.11 | 2.13 | |||
| P/BV | ? | 1.51 | 1.98 | 2.90 | 1.27 | 1.80 | 2.47 | |||
| EV/EBITDA | ? | 5.86 | 6.21 | 7.48 | 3.49 | 5.34 | 10.1 | |||
| Debt/EBITDA | 0.87 | 0.48 | 0.23 | -0.49 | -0.98 | -2.60 | ||||
| Employees, people | 7 752 | 8 274 | 8 461 | 8 466 | 8 805 | |||||
| Labour productivity, mln rub/person/year | 2.08 | 2.31 | 2.98 | 2.98 | 3.14 | |||||
| Expenses per employee, thousand rub | 919.9 | 927.0 | 1 128 | 1 198 | 1 260 | |||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 24% | 20% | 15% | 4% | 13% | 10% | ||||
| GDR MD Medical Group Inv. PLC shareholders | ||||||||||
